Population pharmacokinetics of the anti-PD-1 antibody camrelizumab in patients with multiple tumor types and model-informed dosing strategy

Chenyu Wang, Changcheng Sheng, Guangli Ma, Da Xu, Xiaoqin Liu, Yu-ya Wang, Li Zhang, Chuanliang Cui, Binghe Xu, Yuqin Song, Jun Zhu, Zheng Jiao